The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
He acknowledged the shift in consumer habits: The other thing were seeing in GLP consumers is that theyre keeping our brands in their repertoire
The increased risk sounds bigger in percentage terms (37% to 68% higher) than it looks in real numbers: about 7 in 1,000 GLP-1 patients per year got a hair loss diagnosis, versus 4 to 5 in 1,000 on the comparison drugs
Bill R13.10 when the note says "unable to swallow" and you've got a mismatch that surfaces in an audit
By mimicking natural hormones that regulate appetite and satiety, Semaglutide GLP-1 helps reduce hunger, increase feelings of fullness, and support calorie control, making it an effective tool for weight management in eligible clients